The 32nd National Academic Congress of Urology (CUA 2025) was recently held at the Dalian International Conference Center, bringing together leading urology experts, clinicians, researchers, and industry partners from across China to exchange insights and explore the latest developments shaping the future of urological care.
As a pioneer and longstanding innovator in extracorporeal shock wave technology, WIKKON and Dornier MedTech proudly showcased their latest advancements and strategic vision at this year’s event, reaffirming their shared commitment to advancing modern urology through innovation, clinical value, and international collaboration.
In particular, the Dornier–WIKKON booth drew strong interest from attendees through its showcase of advanced extracorporeal shock wave lithotripsy (ESWL) technologies and integrated lithotripsy solutions.
Team Photo
The event, themed “Empowering Healthcare with Advanced Solutions,” officially unveiled WIKKON’s new brand identity—an important step in WIKKON’s ongoing expansion of products and services in international markets.
Rebranding ceremony
Yau Chung WONG , CEO of AMTH, said, “We are honoured to witness together this important milestone of WIKKON’s new brand identity launch today! As part of AMTH Group’s ongoing growth journey, the new brand is a concrete embodiment of WIKKON’s philosophy: “Empowering Healthcare with Advanced Solutions.”
“We have a deep affection for the Chinese market cultivated over forty years, and together with our global vision, we will continue to focus on clinical value and continuous innovation, to deliver solutions that are more accessible and reliable for every treatment and patient.”
Mr. Yau Chung Wong making his speech
Alex Wu , General Manager of Dornier North Asia and WIKKON, said, “The new brand identity was shaped by our commitment to serving patients and forming like-minded collaboration with strategic partners such as Dornier. “Powered by Dornier” reflects our enhanced manufacturing processes.”
“By tapping on Dornier’s ESWL/ESWT expertise, WIKKON stands to gain important growth that will enable the company to evolve further in their product development to expand internationally.”
Mr. Alex Wu Speech
Dornier MedTech’s legacy in shock wave medical technology began in 1980 with the development of the world’s first ESWL system, the Dornier HM1. This breakthrough technology revolutionized the treatment of urinary stones by introducing non-invasive stone management and is widely regarded as one of the most significant medical innovations of the late 20th century.
Over the past four decades, Dornier MedTech and WIKKON have remained dedicated to advancing shock wave medical technology through continuous innovation and clinical collaboration. Together, both companies have introduced a range of high-value ESWL and ESWT solutions designed to improve treatment precision, efficiency, workflow, and patient outcomes.
World’s First ESWL device – Dornier HM1
Looking ahead, WIKKON and Dornier MedTech will continue building on this strong foundation under the new “WIKKON, Powered by Dornier” brand identity. With continued investment in R&D, manufacturing excellence, and product innovation, we will remain committed to supporting clinicians, advancing the field of urology, and contributing to the future of healthcare.
The Dornier–WIKKON booth also hosted a series of engaging sharing sessions throughout the event.
Distinguished experts including Professor Jia Jianye of Peking University International Hospital, Director Lin Youyue of Rui’an People’s Hospital, and Director Gao Hongwei of the Second Hospital of Tianjin Medical University, who joined the booth to share clinical experiences, treatment perspectives, and insights into the evolving role of ESWL in modern urology practice.
Their presentations sparked lively discussions among attendees and provided valuable opportunities for peer exchange and knowledge sharing.
Professor Jia Jianye Academic Sharing
Director Lin Youyue Academic Sharing
Director Gao Hongwei Academic Sharing
For business enquiries, partnerships, or product-related questions, please leave us a message and our team will be in touch.
Important Notice: This form is for the above general enquiries only and is not intended for medical emergencies, patient-specific medical advice, product complaints, adverse event reports, device malfunction reports, or other safety-related reports.
For product complaints, adverse events, or device malfunctions, please contact our vigilance team at [email protected] or +86-755-25931606 or contact your local distributor. For medical advice, please consult a qualified healthcare professional. For medical emergencies, contact your local emergency services.
